HOME › Press Releases › Allergy Diagnostics Market worth 5.34 Billion USD by 2021
Allergy Diagnostics Market worth 5.34 Billion USD by 2021
The report "Allergy Diagnostics Market by Product (Assay Kits, Instruments (Immunoassay Analyzer, Luminometer), Consumables, Services), by Allergen (Food, Inhaled, Drug), by Tests (In Vivo, In Vitro), by End User (Hospital, Diagnostic Laboratory) - Forecast to 2021", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the allergy diagnostics market along with the estimates and forecasts of the revenue and market shareanalysis.
Browse 88 market data tables with 93 figures spread through 192 pages and in-depth TOC on "Allergy Diagnostics Market by Product (Assay Kits, Instruments (Immunoassay Analyzer, Luminometer), Consumables, Services), by Allergen (Food, Inhaled, Drug), by Tests (In Vivo, In Vitro), by End User (Hospital, Diagnostic Laboratory) - Forecast to 2021"
Early buyers will receive 10% customization on reports.
The global allergy diagnostics market is expected to reach USD 5.34 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 12.4% from 2016 to 2021. The major factors driving the growth of this market are increasing number of allergens and increasing healthcare expenditure worldwide.
In this report, the allergy diagnostics market is segmented based on product, allergen, test, end user, and region. The assay kits segment is expected to account for the largest share of the allergy diagnostics products market in 2016. This segment is also projected to grow at the highest CAGR from 2016 to 2021, owing to the number of allergic diseases.
On the basis of allergen, the allergy diagnostics market is segmented into food allergens, inhaled allergens, drug allergens, and other allergens. The inhaled allergens segment is expected to account for the largest share of this market in 2016, owing to rising CO2 levels in air and the rising prevalence of allergic diseases such as asthma, COPD, and allergic rhinitis.
On the basis of end users, the allergy diagnostics market is segmented into diagnostic laboratories, hospitals, academic research institutes, and other end users. The diagnostic laboratories segment is expected to account for the largest share of the global allergy diagnostics market in 2016. Rise in healthcare spending has resulted in the increasing use of allergy diagnostic products in diagnostic laboratories.
Geographically, the global allergy diagnostics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. Growth in this regional segment is driven by factors such as increase in aging population and increasing pollution due to urbanization.
Key players in the allergy diagnostics market include bioMérieux SA (France), Danaher Corporation (U.S.), Hitachi Chemical Diagnostics, Inc. (Japan), Siemens AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Stallergenes Greer (France), HOB Biotech Group Co., Ltd (China), HYCOR Biomedical (U.S.), Lincoln Diagnostics, Inc. (U.S.), and Omega Diagnostics Group PLC (U.K.).
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India